Inhibition of six copper-containing amine oxidases by the antidepressant drug tranylcypromine

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1647, Issue 1-2, 2003, Pages 252-259

  Shepard, Eric M ^a   Heggem, Heather ^a   Juda, Gregory A ^a   Dooley, David M ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

Amine oxidase; Copper; Enzyme inhibition; Monoamine oxidase; Tranylcypromine

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); TRANYLCYPROMINE; AMINE OXIDASE (COPPER CONTAINING); ANTIDEPRESSANT AGENT; BENZYLAMINE; BENZYLAMINE DERIVATIVE; ENZYME INHIBITOR; PHENYLHYDRAZINE; PHENYLHYDRAZINE DERIVATIVE;

ARTHROBACTER; BINDING AFFINITY; CATALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GEL FILTRATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; ARTICLE; DRUG ANTAGONISM; OXIDATION REDUCTION REACTION; SPECTROSCOPY;

ARTHROBACTER; ARTHROBACTER GLOBIFORMIS; BACTERIA (MICROORGANISMS); BOVINAE; EQUIDAE; MAMMALIA; PICHIA; PICHIA PASTORIS; PISUM SATIVUM;

AMINE OXIDASE (COPPER-CONTAINING); ANTIDEPRESSIVE AGENTS; BENZYLAMINES; ENZYME INHIBITORS; OXIDATION-REDUCTION; PHENYLHYDRAZINES; SPECTRUM ANALYSIS; TRANYLCYPROMINE;

EID: 1242272934     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-9639(03)00062-1     Document Type: Conference Paper

References (52)

1. Plastino J., Green E.L., Sanders-Loehr J., Klinman J.P. An unexpected role for the active site base in cofactor orientation and flexibility in the copper amine oxidase from Hansenula polymorpha. Biochemistry. 38:1999;8204-8216.
2. Wilmot C.M., Murray J.M., Alton G., Parsons M.R., Convery M.A., Blakeley V., Corner A.S., Palcic M.M., Knowles P.F., McPherson M.J., Phillips S.E.V. Catalytic mechanism of the quinoenzyme amine oxidase from Escherichia coli: exploring the reductive half-reaction. Biochemistry. 36:1997;1608-1620.
3. Parsons M.R., Convery M.A., Wilmot C.M., Yadav K.D.S., Blakeley V., Corner A.S., Phillips S.E.V., McPherson M.J., Knowles P.F. Crystal structure of a quinoenzyme: copper amine oxidase of Escherichia coli at 2 Å resolution. Structure. 3:1995;1171-1184.
4. Murray J.M., Saysell C.G., Wilmot C.M., Tambyrajah W.S., Jaeger J., Knowles P.F., Phillips S.E.V., McPherson M.J. The active site base controls cofactor reactivity in Escherichia coli amine oxidase: X-ray crystallographic studies with mutational variants. Biochemistry. 38:1999;8217-8227.
5. Wilmot C.M., Hajdu J., McPherson M.J., Knowles P.F., Phillips S.E.V. Visualization of dioxygen bound to copper during enzyme catalysis. Science. 286:1999;1724-1728.
6. Wilce M.C.J., Dooley D.M., Freeman H.C., Guss J.M., Matsunami H., McIntire W.S., Ruggiero C.E., Tanizawa K., Yamaguchi H. Crystal structures of the copper-containing amine oxidase from Arthrobacter globiformis in the holo and apo forms: implications for the biogenesis of topaquinone. Biochemistry. 36:1997;16116-16133.
7. Elmore B.O., Bollinger J.A., Dooley D.M. Human kidney diamine oxidase: heterologous expression, purification, and characterization. J. Biol. Inorg. Chem. 7:2002;565-579.
8. Green J., Haywood G.W., Large P.J. Serological differences between the multiple amine oxidases of yeast and comparison of the specificities of the purified enzymes from Candida utilis and Pichia pastoris. Biochem. J. 211:1983;481-493.
9. Kagan H.M. Lysyl oxidase: mechanism, regulation and relationship to liver fibrosis. Pathol. Res. Pract. 190:1994;910-919.
10. Wang S.X., Mure M., Medzihradszky K.F., Burlingame A.L., Brown D.E., Dooley D.M., Smith A.J., Kagan H.M., Klinman J.P. A crosslinked cofactor in lysyl oxidase: redox function for amino acid side chains. Science. 273:1996;1078-1084.
11. Boomsma F., van Veldhuisen D.J., de Kam P.J., Man in't Veld A.J., Mosterd A., Lie K.I., Schalekamp M.A. Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc. Res. 33:1997;387-391.
12. Salminen T.A., Smith D.J., Jalkanen S., Johnson M.S. Structural model of the catalytic domain of an enzyme with cell adhesion activity: human vascular adhesion protein-1 (HVAP-1) D4 domain is an amine oxidase. Protein Eng. 11:1998;1195-1204.
13. Bono P., Salmi M., Smith D.J., Jalkanen S. Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity. J. Immunol. 160:1998;5563-5571.
14. Smith D.J., Salmi M., Bono P., Hellman J., Leu T., Jalkanen S. Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J. Exp. Med. 188:1998;17-27.
15. Salmi M., Yegutkin G.C., Lehvonen R., Koskinen K., Salminen T., Jalkanen S. A cell surface amine oxidase directly controls lymphocyte migration. Immunity. 14:2001;265-276.
16. Hevey R.C., Babson J., Maycock A.L., Abeles R.H. Highly specific enzyme inhibitors. Inhibition of plasma amine oxidase. J. Am. Chem. Soc. 95:1973;6125-6127.
17. Tang S.S., Simpson D.E., Kagan H.M. Beta-substituted ethylamine derivatives as suicide inhibitors of lysyl oxidase. J. Biol. Chem. 259:1984;975-979.
18. Medda R., Padiglia A., Pedersen J.Z., Finazzi Agro A., Rotilio G., Floris G. Inhibition of copper amine oxidase by haloamines: a killer product mechanism. Biochemistry. 36:1997;2595-2602.
19. Shepard E.M., Smith J., Elmore B.O., Kuchar J.A., Sayre L.M., Dooley D.M. Towards the development of selective amine oxidase inhibitors. Mechanism-based inhibition of six copper containing amine oxidases. Eur. J. Biochem. 269:2002;3645-3658.
20. Miller J.R., Edmondson D.E. Structure-activity relationships in the oxidation of para-substituted benzylamine analogues by recombinant human liver monoamine oxidase A. Biochemistry. 38:1999;13670-13683.
21. Youdim M.B., Finberg J.P. New directions in monoamine oxidase A and B selective inhibitors and substrates. Biochem. Pharmacol. 41:1991;155-162.
22. Pino R., Lyles G.A. Effect of activity of semicarbazide-sensitive aminooxidases and cellular glutathione on the cytotoxic effect of allylamine, acrolein, and formaldehyde in human cultured endothelial cells. Vopr. Med. Khim. 43:1997;537-547.
23. Blicharski J.R., Lyles G.A. Semicarbazide-sensitive amine oxidase activity in rat aortic cultured smooth muscle cells. J. Neural Transm., Suppl. 32:1990;337-339.
24. Yu P.H., Davis B.A., Boulton A.A. Aliphatic propargylamines, a new series of potent selective, irreversible non-amphetamine-like MAO-B inhibitors. Their structures, function and pharmacological implications. Adv. Exp. Med. Biol. 363:1995;17-23.
25. Abeles R.H., Tashjian A.H. Jr. Comparison of the inhibitory effects of propargylamine and pargyline on brain and liver monoamine oxidase activity. Biochem. Pharmacol. 24:1975;307-308.
26. Boulton A.A., Davis B.A., Durden D.A., Dyck L.E., Juorio A.V., Li X.M., Paterson I.A., Yu P.H. Aliphatic propargylamines: new antiapoptotic drugs. Drug Dev. Res. 42:1997;150-156.
27. Lee Y., Lu X., Silverman R.B., Shepard E.M., Dooley D.M., Sayre L.M. 3-pyrrolines are mechanism-based inactivators of the quinone dependent amine oxidases, but only substrates of the flavin dependent amine oxidases. J. Am. Chem. Soc. 124:2002;12135-12143.
28. Weber-Grandke H., Hahn G., Mutschler E., Mohrke W., Langguth P., Spahn-Langguth H. The pharmokinetics of tranylcypromine enantiomers in healthy subjects after oral administration of racemic drug and single enantiomers. Br. J. Clin. Pharmacol. 36:1993;363-365.
29. Mallinger A.G., Himmelhoch J.M., Thase M.E., Edwards D.J., Knopf S. Plasma tranylcypromine: relationship to pharmacokinetic variables and clinical antidepressant actions. J. Clin. Psychopharmacol. 10:1990;176-183.
30. Paech C., Salach J.I., Singer T.P. Suicide inactivation of monoamine oxidase by trans-phenylcyclopropylamine. Singer T.P., Von Korff R.W., Murphy D.L. Monoamine Oxidase: Structure, Function, and Altered Functions. 1979;Academic Press, New York.
31. Moises H.W., Beckmann H. Antidepressant efficacy of tranylcypromine isomers: a controlled study. J. Neural Transm. 50:1981;185-192.
32. Horn A.S., Snyder S.H. Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine. J. Pharmacol. Exp. Ther. 180:1972;523-530.
33. Roh J.H., Suzuki H., Azakami H., Yamashita M., Murooka Y., Kumagai H. Purification, characterization, and crystallization of monoamine oxidase from Escherichia coli K-12. Biosci. Biotechnol. Biochem. 58:1994;1652-1656.
34. Saysell C.G., Tambyrajah W.S., Murray J.M., Wilmot C.M., Phillips S.E.V., McPherson M.J., Knowles P.F. Probing the catalytic mechanism of E. coli amine oxidase through use of mutants and a reversible inhibitor as a substrate analogue. Biochem. J. 365:2002;809-816.
35. Juda G.A., Bollinger J.A., Dooley D.M. Construction, overexpression, and purification of Arthrobacter globiformis amine oxidase-Strep-Tag II fusion protein. Protein Expr. Purif. 22:2001;455-461.
36. Carter S.R., McGuirl M.A., Brown D.E., Dooley D.M. Purification and active-site characterization of equine plasma amine oxidase. J. Inorg. Biochem. 56:1994;127-141.
37. McGuirl M.A., McCahon C.D., McKeown K.A., Dooley D.M. Purification and characterization of pea seedling amine oxidase for crystallization studies. Plant Physiol. 106:1994;1205-1211.
38. Suzuki S., Sakurai T., Nakahara A., Manabe T., Okuyama T. Effect of metal substitution on the chromophore of bovine serum amine oxidase. Biochemistry. 22:1983;1630-1635.
39. Kuchar J., Dooley D.M. Cloning, sequence analysis, and characterization of the "lysyl oxidase" from Pichia pastoris. J. Inorg. Biochem. 83:2001;193-204.
40. Janes S.M., Klinman J.P. An investigation of bovine serum amine oxidase active site stoichiometry: evidence for an aminotransferase mechanism involving two carbonyl cofactors per enzyme dimer. Biochemistry. 30:1991;4599-4605.
41. Brown D.E., McGuirl M.A., Dooley D.M., Janes S.M., Mu D., Klinman J.P. The organic functional group in copper-containing amine oxidases. Resonance Raman spectra are consistent with the presence of topa quinone (6-hydroxydopa quinone) in the active site. J. Biol. Chem. 266:1991;4049-4051.
42. Szutowicz A., Kobes R.D., Orsulak P.J. Colorimetric assay for monoamine oxidase in tissues using peroxidase and 2,2′-azinodi(3- ethylbenzthiazoline-6-sulfonic acid) as chromogen. Anal. Biochem. 138:1984;86-94.
43. Moenne-Loccoz P., Nakamura N., Steinebach V., Duine J.A., Mure M., Klinman J.P., Sanders-Loehr J. Characterization of the topa quinone cofactor in amine oxidase from Escherichia coli by resonance Raman spectroscopy. Biochemistry. 34:1995;7020-7026.
44. Mure M., Mills S.A., Klinman J.P. Catalytic mechanism of the topa quinone containing copper amine oxidases. Biochemistry. 41:2002;9269-9278.
45. Dooley D.M., McGuirl M.A., Brown D.E., Turowski P.N., McIntire W.S., Knowles P.F. A Cu(I)-semiquinone state in substrate-reduced amine oxidases. Nature. 349:1991;262-264.
46. Medda R., Padiglia A., Bellelli A., Sarti P., Santanche S., Finazzi Agro A., Floris G. Intermediates in the catalytic cycle of lentil (Lens esculenta) seedling copper-containing amine oxidase. Biochem. J. 332:1998;431-437.
47. Hacisalihoglu A., Jongejan A., Jongejan J.A., Duine J. Enantioselective oxidation of amphetamine by copper-containing quinoprotein amine oxidases from E. coli and Klebsiella oxytoca. J. Mol. Catal., B: Enzym. 11:2000;81-88.
48. Coleman A.A., Scaman C.H., Kang Y.J., Palcic M.M. Stereochemical trends in copper amine oxidase reactions. J. Biol. Chem. 266:1991;6795-6800.
49. Alton G., Taher T.H., Beever R.J., Palcic M.M. Stereochemistry of benzylamine oxidation by copper amine oxidases. Arch. Biochem. Biophys. 316:1995;353-361.
50. Coleman A.A., Hindsgaul O., Palcic M.M. Stereochemistry of copper amine oxidase reactions. J. Biol. Chem. 264:1989;19500-19505.
51. Fitzgerald D.H., Tipton K.F., Lyles G.A. Studies on the behaviour of semicarbazide-sensitive amine oxidase in Sprague-Dawley rats treated with the monoamine oxidase inhibitor tranylcypromine. J. Neural Transm., Suppl. 52:1998;259-264.
52. Fitzgerald D.H., Tipton K.F. Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO). J. Neural Transm. 109:2002;251-265.